LAB has awarded $1.69 million (approx. S$2.2 million) to an A*STAR-led research team developing a potential first-in-class ...

ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery ...

Roche inks $1.06Billion deal with China's Rona for ALK7-targeting RNAi therapy for obesity and metabolic diseases ...

The University of Melbourne, Australia and the Indian Institute of Science Education and Research (IISER) Tirupati have ...

Singapore and global biopharmaceutical company Boehringer Ingelheim will be investigating new approaches to treating obesity, ...

Insilico Medicine’s Feng Ren discusses AI drug discovery, clinical development and Asia’s role in turning computational ...

In addition to the NMPA's approval of CAMCEVI ® 42 mg for advanced prostate cancer described above, GenSci submitted a ...

Japan's Ono Pharma inks exclusive license agreement with Biohaven to develop and commercialise IgG degraders in Japan, South ...

Philanthropy Asia Alliance backs the NUS Medicine-based Southeast Asia Heat Health Hub, supporting heat-health action in ...

Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through the ...

S$25 million Healthy Longevity Institute and global brain health collaboration to advance healthy ageing in Singapore ...

Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for core ...